Summary: Findings reveal the molecular mechanism for acetylcholine in learning and memory.

Source: Fujita Health University.

Patients with Alzheimer’s disease (AD) have lower levels of the neuromodulator acetylcholine (ACh) in their brains. Donepezil, an AD drug, increases brain ACh levels and improves AD-associated learning deficits.